<DOC>
	<DOC>NCT00147563</DOC>
	<brief_summary>To investigate the impact of antihypertensive therapy with the selective mineralocorticoid receptor blocker, eplerenone, on small resistance artery remodeling, compared to the effect of equivalent blood pressure control achieved with a b-blocker, atenolol.</brief_summary>
	<brief_title>Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Pt with essential hypertension who have never been treated or untreated within the previous 6 months History of Malignant Hypertension Sitting diastolic blood pressure &gt; 115mmHg or sitting Systolic blood pressure &gt; 200mmHg</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>